John D'Alotto

John D'Alotto has extensive experience in the pharmaceutical and healthcare industry, with a focus on insights, analytics, and market research. John is currently serving as the Senior Director of Insights and Analytics at Fosun Pharma USA Inc. Previously, they held the position of Director of New Product Planning Insights at Takeda from November 2019 to June 2022. Prior to that, they served as the Senior Director of Market Analytics at Agios Pharmaceuticals from December 2017 to September 2019.

John also spent a significant portion of their career at Shire, where they held various leadership roles. John was the Head of Analytics for Immunology from May 2015 to November 2017 and the Senior Director of Global Commercial Operations from June 2014 to April 2015. Before that, they served as the Director of Business Insights for The Americas & Asia Pacific from March 2011 to May 2014 and the Director of Global Analytics & Market Research from an unspecified start date in 2006 to February 2011.

In addition, John worked at Biogen Idec as the Associate Director of Decision Support from an unspecified start date in 2000 to an unspecified end date in 2005. John played a key role in the launch of a new therapy for Hunters Syndrome, conducting sales forecasting and developing sales strategies. Before entering the pharmaceutical industry, John worked as a Senior Consultant at PwC, where they managed business valuation projects for healthcare clients from 1994 to 2000.

Overall, John D'Alotto has a strong background in pharmaceutical insights and analytics, with experience spanning multiple companies and leadership roles.

John D'Alotto has an MBA in Finance from the Bentley University - McCallum Graduate School of Business. John also holds a BS in Finance from Providence College. No specific start or end years are provided for either degree.